Search Results

There are 13331 results for: content related to: Inhibitors: our greatest challenge. Can we minimize the incidence?

  1. You have free access to this content
    Achievements, challenges and unmet needs for haemophilia patients with inhibitors

    Haemophilia

    Volume 22, Issue S1, January 2016, Pages: 1–24, Y. Dargaud, A. Pavlova, S. Lacroix-Desmazes, K. Fischer, M. Soucie, S. Claeyssens, D.w. Scott, R. d'Oiron, G. Lavigne-Lissalde, G. Kenet, C. Escuriola Ettingshausen, A. Borel-Derlon, T. Lambert, G. Pasta and C. Négrier

    Version of Record online : 5 JAN 2016, DOI: 10.1111/hae.12860

  2. You have free access to this content
    Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 2–16, P. M. Mannucci, Q. Shi, S. Bonanad and R. Klamroth

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12465

    Corrected by:

    Erratum: Erratum

    Vol. 20, Issue 5, e376, Version of Record online: 28 AUG 2014

  3. The role of previously untreated patient studies in understanding the development of FVIII inhibitors

    Haemophilia

    Volume 22, Issue 1, January 2016, Pages: 22–31, M. Carcao, W. Re and B. Ewenstein

    Version of Record online : 27 AUG 2015, DOI: 10.1111/hae.12790

  4. You have free access to this content
    Inhibitors – genetic and environmental factors

    Haemophilia

    Volume 20, Issue s4, May 2014, Pages: 87–93, D. Lillicrap, K. Fijnvandraat and E. Santagostino

    Version of Record online : 25 APR 2014, DOI: 10.1111/hae.12412

  5. You have free access to this content
    New predictive approaches for ITI treatment

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 27–43, G. D. Minno, E. Santagostino, K. Pratt and C. Königs

    Version of Record online : 26 JUN 2014, DOI: 10.1111/hae.12467

  6. You have full text access to this OnlineOpen article
    Inhibitors in haemophilia A: a perspective on clotting factor products as a potential contributing factor

    Haemophilia

    Volume 22, Issue 3, May 2016, Pages: 334–341, P. Mathew, H. Dinter, N. Church, T. J. Humphries and R. Kulkarni

    Version of Record online : 4 FEB 2016, DOI: 10.1111/hae.12888

  7. You have full text access to this OnlineOpen article
    Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: 905–911, M. I. Bravo, B. Da Rocha-Souto, S. Grancha and J. I. Jorquera

    Version of Record online : 25 AUG 2014, DOI: 10.1111/hae.12494

  8. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 721–729, K. Vepsäläinen, R. Lassila, M. Arola, P. Huttunen, S. Koskinen, R. Ljung, P. Lähteenmäki, M. Möttönen and P. Riikonen

    Version of Record online : 24 JUN 2016, DOI: 10.1111/hae.12974

  9. Non-genetic risk factors in haemophilia A inhibitor management – the danger theory and the use of animal models

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 657–666, K. M. Lövgren, H. Søndergaard, S. Skov and B. Wiinberg

    Version of Record online : 26 AUG 2016, DOI: 10.1111/hae.13075

  10. Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: Non-interventional, observational study in patients with severe haemophilia A

    Haemophilia

    Volume 21, Issue 1, January 2015, Pages: e19–e25, K. Meijer, S. Rauchensteiner, E. Santagostino, H. Platokouki, R. E. G. Schutgens, M. Brunn, C. Tueckmantel, F. Valeri and P. C. Schinco

    Version of Record online : 2 DEC 2014, DOI: 10.1111/hae.12530

  11. You have free access to this content
    Guidelines for the management of hemophilia

    Haemophilia

    Volume 19, Issue 1, January 2013, Pages: e1–e47, A. Srivastava, A. K. Brewer, E. P. Mauser-Bunschoten, N. S. Key, S. Kitchen, A. Llinas, C. A. Ludlam, J. N. Mahlangu, K. Mulder, M. C. Poon, A. Street and Treatment Guidelines Working Group The World Federation Of Hemophilia

    Version of Record online : 6 JUL 2012, DOI: 10.1111/j.1365-2516.2012.02909.x

  12. The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro

    Haemophilia

    Volume 18, Issue 6, November 2012, Pages: 917–925, F. A. Ofosu, H. Tse, A. Naqvi, H. Bhakta and Y. Song

    Version of Record online : 3 JUN 2012, DOI: 10.1111/j.1365-2516.2012.02861.x

  13. Kinetics of the interaction between anti-FVIII antibodies and FVIII from therapeutic concentrates, with and without von Willebrand factor, assessed by surface plasmon resonance

    Haemophilia

    Volume 18, Issue 6, November 2012, Pages: 982–989, S. Grancha, A. M. Ortiz, C. Marañón, K. Hampel, A. Moret, B. Zimmermann, J. I. Jorquera and J. A. Aznar

    Version of Record online : 30 MAY 2012, DOI: 10.1111/j.1365-2516.2012.02858.x

  14. Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: e151–e166, L. A. Valentino, G. Allen, J. C. Gill, A. Hurlet, B. A. Konkle, C. A. Leissinger, L. Luchtman-Jones, J. Powell, M. Reding and K. Stine

    Version of Record online : 4 FEB 2013, DOI: 10.1111/hae.12095

  15. Spotlight on the human factor: building a foundation for the future of haemophilia A management

    Haemophilia

    Volume 21, Issue s1, January 2015, Pages: 1–12, C. Kessler, J. Oldenburg, C. Escuriola Ettingshausen, A. Tiede, K. Khair, C. Négrier and R. Klamroth

    Version of Record online : 4 DEC 2014, DOI: 10.1111/hae.12582

  16. Infection risk and stability of a continuous 8-h 250 mL rFVIII infusion

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: 212–218, A. Lambing, P. Kuriakose and L. M. Mueller

    Version of Record online : 20 NOV 2013, DOI: 10.1111/hae.12292

  17. Predictive immunogenicity of Refacto®AF

    Haemophilia

    Volume 20, Issue 4, July 2014, Pages: 486–492, S. Delignat, Y. Repessé, L. Gilardin, J. D. Dimitrov, Y.C. Lone, S. V. Kaveri and S. Lacroix-Desmazes

    Version of Record online : 30 DEC 2013, DOI: 10.1111/hae.12348

  18. You have free access to this content
    Managing Haemophilia for Life: 4th Haemophilia Global Summit

    Haemophilia

    Volume 20, Issue s5, July 2014, Pages: 1–20, J. Astermark, G. Dolan, T. Hilberg, V. Jiménez-Yuste, M. Laffan, R. Lassila, S. Lobet, C. Martinoli and C.-F. Perno

    Version of Record online : 13 JUN 2014, DOI: 10.1111/hae.12468

  19. Product-dependent anti-factor VIII antibodies

    Haemophilia

    Volume 19, Issue 4, July 2013, Pages: 619–625, S. Butenas, J. Krudysz-Amblo, G. E. Rivard and K. G Mann

    Version of Record online : 4 APR 2013, DOI: 10.1111/hae.12127

  20. Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: 200–206, D. Matino, D. Lillicrap, J. Astermark, G. Dolan, C. Kessler, T. Lambert, M. Makris, J. O'Donnell, S. Pipe, E. Santagostino, J.-M. Saint-Remy, W. Schramm and A. Iorio

    Version of Record online : 29 OCT 2013, DOI: 10.1111/hae.12283